Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar 26;24(4):103756.
doi: 10.1016/j.autrev.2025.103756. Epub 2025 Jan 23.

Neuropsychiatric manifestations in systemic lupus erythematosus and Sjogren's disease

Affiliations
Review

Neuropsychiatric manifestations in systemic lupus erythematosus and Sjogren's disease

Amanda Carolina Miranda Costa et al. Autoimmun Rev. .

Abstract

Introduction: Autoimmune diseases often present in a systemic manner, affecting various organs and tissues. Involvement of the central and peripheral nervous system is not uncommon in these conditions and is associated with high morbidity and mortality. Therefore, early recognition of the neuropsychiatric manifestations associated with rheumatologic diseases is essential for the introduction of appropriate therapies with the objective of providing a better quality of life for individuals.

Objective: To provide a literature review of the neuropsychiatric manifestations related to Systemic Lupus Erythematosus (SLE) and primary Sjögren's Disease (pSD), through the description of signs, symptoms, and immunological variables associated with these conditions.

Methods: A literature review was conducted by searching for national and international articles available in the SciELO and PubMed databases related to the description of neurological and psychiatric manifestations in patients with the rheumatologic diseases of interest in this study.

Results: The main NP manifestations presented in SLE and pSD are discussed, focusing on clinical presentation and etiology. Treatment option are, however, mainly based on expert opinion, since a few randomized controlled trials have been done.

Conclusions: There is a high prevalence of neuropsychiatric manifestations associated with SLE and pSD. The variety of physiopathology pathways may explain the variety of symptoms, however pathological findings are rare. Multicenter studies on attribution protocols and treatment are necessary to address the current gaps.

Keywords: Neuropsychiatric manifestations; Sjogren's disease; Systemic Lupus Erythematosus.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest All authors have declared their conflicts. TBN has received research grants from EMD Serono, Zenas Biopharma, and Progentec, and has consulted for Thermo Fisher, Inova, Roivant Sciences, Ventus Therapeutics, Pioneering Medicines, Toran Therapeutics, and Progentec, Inc. all unrelated to the current manuscript. SA has research grant with GSK, unrelated to the current manuscript. No other conflicts were declared by other authors.

MeSH terms

LinkOut - more resources